Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
173 hedge funds and large institutions have $462M invested in Meridian Bioscience Inc in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 51 reducing their positions, and 40 closing their positions.
152% more call options, than puts
Call options by funds: $569K | Put options by funds: $226K
4% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 51
5% less funds holding
Funds holding: 183 → 173 (-10)
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
34% less capital invested
Capital invested by funds: $701M → $462M (-$239M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.58M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$2.83M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.79M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$25.8M |
| 2 |
Morgan Stanley
New York
|
-$3.23M |
| 3 |
CIS
Connors Investor Services
Wyomissing,
Pennsylvania
|
-$3.03M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.9M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$2.32M |
VIVO Hedge Fund Activity: Q2 2019 in Review
173 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2019, worth a combined $462M — down 34% from $701M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of VIVO and 34 opened new positions — a net loss of 6 holders — while 51 trimmed existing stakes and 53 added.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $8.58M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $25.8M sold.
- 173 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2019, down from 183 in Q1 2019.
- Funds reported $462M of Meridian Bioscience Inc stock for Q2 2019, down 34% quarter-over-quarter.
- 34 funds opened new Meridian Bioscience Inc positions in Q2 2019 and 40 closed out, a net change of -6 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2019 was Assenagon Asset Management, an estimated $8.58M added.
- The largest Meridian Bioscience Inc seller in Q2 2019 was Vaughan Nelson Investment Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q2 2019.